SCT BIO Trademark

Trademark Overview


On Thursday, April 14, 2022, a trademark application was filed for SCT BIO with the United States Patent and Trademark Office. The USPTO has given the SCT BIO trademark a serial number of 79345925. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by SCTbio a.s.. The SCT BIO trademark is filed in the Transportation & Storage Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others

Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials

Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies
sct bio

General Information


Serial Number79345925
Word MarkSCT BIO
Filing DateThursday, April 14, 2022
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7238443
Registration DateTuesday, December 12, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 26, 2023

Trademark Statements


Goods and ServicesManufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
Description of MarkThe mark consists of the stylized letters "SCT" in red followed by the stylized letters "BIO" in turquoise.
Goods and ServicesPackaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
Indication of Colors claimedThe color(s) red and turquoise is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies

Classification Information


International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes103, 106, 100
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSCT Cell Manufacturing s.r.o.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCZ

Party NameSCT Cell Manufacturing s.r.o.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCZ

Party NameSCT Cell Manufacturing s.r.o.
Party Type12 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCZ

Party NameSCT Cell Manufacturing s.r.o.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCZ

Party NameSCTbio a.s.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCZ

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 13, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 13, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 12, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023PUBLISHED FOR OPPOSITION
Monday, September 25, 2023NOTIFICATION PROCESSED BY IB
Wednesday, September 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 6, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, August 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 23, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 23, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Wednesday, January 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 25, 2023REFUSAL PROCESSED BY MPU
Friday, January 20, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, December 25, 2022CHANGE OF OWNER RECEIVED FROM IB
Thursday, November 24, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 23, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2022ASSIGNED TO EXAMINER
Friday, November 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 2, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB